Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00RMD
|
|||
| Former ID |
DIB002983
|
|||
| Drug Name |
FK-960
|
|||
| Synonyms |
UNII-2GB92V6H2O; 2GB92V6H2O; FK-960; FK-960 hydrate; FK-960 monohydrate; AC1OCFBG; SCHEMBL3089403; FR-59960; LS-25245; N-(4-acetylpiperazin-1-yl)-4-fluorobenzamide hydrate; Benzamide, N-(4-acetyl-1-piperazinyl)-4-fluoro-, hydrate (1:1)
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cognitive impairment [ICD-11: 6D71; ICD-10: F06.7] | Discontinued in Phase 2 | [1] | |
| Company |
Fujisawa Pharmaceutical Co Ltd
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H16FN3O2
|
|||
| Canonical SMILES |
CC(=O)N1CCN(CC1)NC(=O)C2=CC=C(C=C2)F
|
|||
| InChI |
1S/C13H16FN3O2/c1-10(18)16-6-8-17(9-7-16)15-13(19)11-2-4-12(14)5-3-11/h2-5H,6-9H2,1H3,(H,15,19)
|
|||
| InChIKey |
XTOKQKWTUYYVAO-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 133920-70-4
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Somatostatin receptor (SSTR) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008887) | |||
| REF 2 | FK960, a novel potential anti-dementia drug, enhances high K(+)-evoked release of somatostatin from rat hippocampal slices. Brain Res. 2001 Feb 16;892(1):111-7. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.